Health sector involvement in the management of female genital mutilation/cutting in 30 countries

Background: For the last decades, the international community has emphasised the importance of a multisectoral approach to tackle female genital mutilation (FGM/C). While considerable improvement concerning legislations and community involvement is reported, little is known about the involvement of the health sector. Method: A mixed methods approach was employed to map the involvement of the health sector in the management of FGM/C both in countries where FGM/C is a traditional practice (countries of origin), and countries where FGM/C is practiced mainly by migrant populations (countries of migration). Data was collected in 2016 using a pilot-tested questionnaire from 30 countries (11 countries of origin and 19 countries of migration). In 2017, interviews were conducted to check for data accuracy and to request relevant explanations. Qualitative data was used to elucidate the quantitative data. Results: A total of 24 countries had a policy on FGM/C, of which 19 had assigned coordination bodies and 20 had partially or fully implemented the plans. Nevertheless, allocation of funding and incorporation of monitoring and evaluation systems was lacking in 11 and 13 of these countries respectively. The level of the health sectors' involvement varied considerably across and within countries. Systematic training of healthcare providers (HCP) was more prevalent in countries of origin, whereas involvement of HCP in the prevention of FGM/C was more prevalent in countries of migration. Most countries reported to forbid HCP from conducting FGM/C on both minors and adults, but not consistently forbidding re-infibulation. Availability of healthcare services for girls and women with FGM/C related complications also varied between countries dependent on the type of services. Deinfibulation was available in almost all countries, while clitoral reconstruction and psychological and sexual counselling were available predominantly in countries of migration and then in less than half the countries. Finally, systematic recording of FGM/C in medical records was completely lacking in countries of origin and very limited in countries of migration. Conclusion: Substantial progress has been made in the involvement of the health sector in both the treatment and prevention of FGM/C. Still, there are several areas in need for improvement, particularly monitoring and evaluatio

A New Model for Understanding the Growth of Science Teacher Professional Knowledge.

International audienc

Aspergilose invasiva do seio esfenoidal e paralisia do sexto nervo

A aspergilose do seio esfenoidal é doença rara e pode se apresentar sob diferentes formas clínicas devido a envolvimento de. diversas estruturas anatomicamente adjacentes ao seio esfenoidal. Relatamos o caso de uma paciente com 74 anos de idade, diabética, com paralisia do sexto nervo esquerdo secundária a aspergilose do seio esfenoidal. Não havia história de cefaléia ou de queixas sugestivas de alergia respiratória. A tomografia computadorizada revelou lesão etmoídeo-esfenoidal à esquerda, com presença de imagem cálcica em seu interior e destruição óssea. A paciente foi submetida a cirurgia com retirada de material necrótico e debridamento da lesão, seguida de tratamento com anfote-ricina B e 5-fluorocitosina. Exame histológico revelou a presença de hifas sugestivas de Aspergilius sp. Após três meses de tratamento a paciente apresentou recuperação total da paresia do nervo abducente. O diagnóstico clínico pré-operatório de aspergilose do seio esfenoidal é difícil. No entanto, a presença de imagem cálcica ou de densidade metálica à radiografia simples de crânio ou à tomografia computadorizada sugere fortemente o diagnóstico. O exame hihstológico revela a presença de hifas dicotomatosas em 45,0 típicas do Aspergilius. O tratamento inclui excisão e debridamento da lesão seguida do uso de anfo-tericina B associada a 5-fluorocitosina ou rifampicina